StockData
Champions Oncology, Inc. logo

Champions Oncology, Inc. (CSBR) stock

CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/30245% above fair value
$4.68−0.03 (-0.53%)

Close on Nov 16, 2026Market cap $65.14MP/E –Yield –

Champions Oncology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Champions Oncology's price to book ratio was 17.1× on Nov 11, 2026, against 25.7× a year earlier. Over the last 5 years it ranged from 6.1× to 221.1×, with a median of 18.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202617.1×−5.9
2025Dec 31, 202523.0×−149.4
2024Dec 31, 2024172.4×+135.9
2023Nov 30, 202336.5×+29.8
2022Dec 30, 20226.7×−7.3
2021Dec 31, 202114.0×−6.9
2020Dec 31, 202020.9×−24.9
2019Dec 31, 201945.8×+0.8
2018Dec 31, 201845.0×−69.3
2017Dec 29, 2017114.3×+105.6
2016Dec 30, 20168.7×+1.1
2015Dec 31, 20157.6×−89.9
2014Nov 28, 201497.5×–

More Champions Oncology figures

See a number that looks wrong?